Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pain 3Carcinoma, Hepatocellular 3Stomach Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Liver Diseases 1Inflammation 1Esophageal Neoplasms 1Emergence Delirium 1

Interventions

Acupuncture Therapy 4Sufentanil 3Radiotherapy 3Psychiatric Rehabilitation 3Early Intervention, Educational 3Analgesia 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Yoga 2Transcutaneous Electric Nerve Stimulation 2Therapeutics 2Surveys and Questionnaires 2Ropivacaine 2Palliative Care 2Morphine 2Interviews as Topic 2Ethanol 2Esketamine 2Electroacupuncture 2Capecitabine 2Uncertainty 1Transcranial Magnetic Stimulation 1Sensitivity Training Groups 1Saline Solution 1Psychosocial Intervention 1Oxycodone 1Minocycline 1Methods 1Mental Status and Dementia Tests 1Meditation 1Massage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pain × Sufentanil × Gastrointestinal × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

NCT05670561 2023-03-29

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

NCT05416073 2023-02-24

TACE-HAIC

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡